Sanaria

Sanaria is a biotechnology company dedicated to producing vaccines for the prevention of malaria caused by Plasmodium falciparum. Sanaria's vaccine is based on an immunization method that has been shown to provide a high level of protection in humans. Sanaria's primary mission is to develop and commercialize whole sporozoite vaccines that offer a high level, long-lasting protection against Plasmodium falciparum, which is responsible for over 95% of severe malaria-related illnesses and deaths globally, as well as being the malaria parasite with the most significant drug resistance. The overall mission includes developing vaccines to prevent all forms of human malaria.